Products

PRAEVAorta®2
Nurea
Cardiology AI
PRAEVAorta®2 is Nurea's FDA-cleared, AI-powered software for automated segmentation and geometric analysis of vessels from CT images, supporting diagnosis and follow-up of vascular diseases like aortic aneurysms with a "0 click" workflow.

See all 1 product →

About Nurea

Nurea is a healthcare AI company specializing in advanced medical imaging software for the prevention and diagnosis of cardiovascular and neurovascular diseases. Their technology leverages artificial intelligence to create precise three-dimensional reconstructions of patients’ arterial systems from standard two-dimensional medical images. This innovative approach enables clinicians to identify early signs of aneurysms and other critical conditions before they become life-threatening, offering an accurate, operator-independent solution that integrates seamlessly into existing hospital systems.

The company’s flagship product, PRAEVAorta® 2, is an AI-powered software designed to assist physicians in the diagnosis and management of aortic aneurysms. It automates the analysis of contrast-enhanced or non-contrast CT scans, generating precise measurements of the aorta, including diameter and aneurysm volume. The software can also differentiate between the thrombus and lumen, providing deeper insights into disease severity. This “zero-click” solution significantly reduces the time and effort required for clinicians to extract meaningful data, supporting continuous monitoring throughout a patient’s care journey from initial detection to long-term surveillance.

Nurea’s mission is to enhance patient care through improved prevention and follow-up, while simultaneously simplifying the workflow for physicians by providing powerful, user-friendly technologies that facilitate accurate, faster, and earlier diagnoses. Their healthtech is built upon biomedical modeling, 3D numerical simulations, and artificial intelligence.

What Physicians Need to Know

Specialization: Cardiovascular & Neurovascular AI
Nurea specializes in AI-powered medical imaging software, primarily for the automated analysis of CT scans to diagnose and monitor cardiovascular and neurovascular diseases. Their flagship product, PRAEVAortau00ae 2, focuses on aortic aneurysms.
Core Technology: Biomedical Modeling & AI
Their healthtech is built upon a foundation of biomedical modeling, 3D numerical simulations, and advanced Artificial Intelligence algorithms.
Key Differentiator: Automated, Precise Analysis
Nurea's PRAEVAortau00ae 2 offers automated reconstruction and analysis of the arterial tree from DICOM images, significantly reducing interobserver variability and providing accurate, operator-independent solutions for conditions like aortic aneurysms.
Key Differentiator: Efficiency & Cost Reduction
The software drastically cuts expert interpretation time by up to 95% (e.g., 4 minutes from image acquisition to report availability) and has the potential to halve annual US screening costs for abdominal aortic aneurysms (AAAs) through incidental detection on various CT scans.
Regulatory Milestones
Nurea's PRAEVAortau00ae 2 has received US Food and Drug Administration (FDA) 510(k) clearance and CE mark approval, enabling its use in both the United States and the European Union.
Physician Tip

For physicians, Nurea's tools, particularly PRAEVAortau00ae 2, offer enhanced diagnostic confidence and precision by providing automated, standardized measurements and visualizations of the arterial system. This leads to significantly reduced interpretation times, allowing for faster diagnoses and more efficient surgical planning for vascular diseases. The ability to identify early signs of aneurysms and monitor their progression over time supports proactive, personalized patient care and can ultimately improve patient outcomes by reducing mortality. Its seamless integration into existing clinical workflows minimizes disruption, making it a practical addition to daily practice.

Nurea's solution, PRAEVAortau00ae 2, is designed for seamless integration into existing hospital systems and everyday clinical tools, including PACS, workstations, and imaging software. They have also partnered with companies like deepc to integrate their AI solutions into broader platforms like deepcOS, further enhancing accessibility for radiologists and surgeons.

Products by Nurea

1 product in the directory

PRAEVAorta®2
Nurea
Cardiology AI
PRAEVAorta®2 is Nurea's FDA-cleared, AI-powered software for automated segmentation and geometric analysis of vessels from CT images, supporting diagnosis and follow-up of vascular diseases like aortic aneurysms with a "0 click" workflow.

What the Web Says

Nurea, a company specializing in AI-powered medical imaging solutions, receives generally positive feedback for its product's ability to automate and enhance cardiovascular analysis, particularly for CT scans. Users appreciate the time-saving aspects and accuracy. As an employer, information is scarce, but the focus seems to be on a collaborative and innovative environment.

Overall: Positive

Strengths

  • Automates and accelerates cardiovascular CT scan analysis
  • Improves accuracy and consistency in measurements (e.g., aortic valve, coronary calcium)
  • Reduces manual workload for radiologists and cardiologists
  • User-friendly interface and intuitive workflow
  • Potential for early detection and better patient management
  • Strong scientific backing and clinical validation

Limitations

  • Limited information available on employer reviews (Glassdoor, Reddit)
  • Specific pricing details are not readily public
  • Integration challenges with existing PACS systems for some users (though not widely reported)
  • Reliance on high-quality input data for optimal results
  • Potential learning curve for new users unfamiliar with AI tools
  • Specific product limitations for less common cardiovascular conditions not explicitly detailed in reviews

Based on reviews from: G2, Capterra, Healthcare IT News/Review Sites, Company Website/Press Releases

Last updated: 2026-07-20

Videos

News, demos, and interviews about Nurea.

Loading videos...

Videos load interactively. If none appear, search YouTube for Nurea →

View all on YouTube

Press & Coverage

Business Wire
Nurea Receives FDA Clearance for PRAEVAortau00ae2, Bringing Advanced Aortic Aneurysm Management to the U.S. Market
Nurea's PRAEVAortau00ae2 software, an AI-powered medical imaging solution for aortic aneurysm management, has received FDA 510(k) clearance, allowing its entry into the U.S. market. This software provides advanced automated measurement tools for aortic diameters on CT scans, aiming to improve diagnostic decision-making and patient follow-up while reducing costs.
2025-10
Applied Radiology
Nurea Gains FDA Clearance for AI Tool Designed to Improve Aortic Aneurysm Diagnosis and Management
Nurea, a French medtech firm, has secured FDA clearance for its PRAEVAorta 2 software, an AI-powered solution for diagnosing and managing aortic aneurysms. The software automates the analysis of CT scans, providing precise measurements and distinguishing between thrombus and lumen to aid in early detection and continuous monitoring.
2025-10
G-MedTech
Nurea Gains FDA Clearance for PRAEVAortau00ae2, Expanding AI-Driven Aortic Aneurysm Management to the U.S.
Nurea's AI-powered PRAEVAortau00ae2 software has received FDA 510(k) clearance, enabling its use in U.S. healthcare settings for advanced automation in aortic aneurysm diagnosis, follow-up, and patient management. This solution aims to enhance diagnostic precision and streamline patient care.
2025-10
DAIC
Nurea Receives FDA Clearance for PRAEVAorta 2
Nurea announced FDA 510(k) clearance for its PRAEVAorta 2 software, an AI-powered tool designed to assist vascular physicians in diagnostic decision-making and patient follow-up for aortic aneurysms. The software aims to improve reliability and accuracy while reducing the cost of care.
2025-10
PubMed / Journal of Endovascular Therapy
External Validation of Fully-Automated Infrarenal Maximum Aortic Aneurysm Diameter Measurements in Computed Tomography Angiography Scans Using Artificial Intelligence (PRAEVAorta 2)
This study validates the accuracy of Nurea's PRAEVAorta 2 AI software for fully-automated maximum aortic diameter measurements in abdominal aortic aneurysm patients using CT angiography scans. The results show excellent correlation with core laboratory measurements, suggesting its potential as an important adjunct for research and clinical practice.
2024-11
NUREA Newsroom
Blackford and Nurea Announce Partnership to Bring Cardiovascular Analysis Software to Healthcare Providers
Blackford and Nurea have partnered to deliver Nurea's cardiovascular analysis software to healthcare providers. This collaboration aims to expand the reach of Nurea's AI-powered solutions for vascular disease management.
2023-12
NUREA Newsroom
NUREA receives CE marking (class 2b) for its software PRAEVAortau00ae 2
Nurea's PRAEVAortau00ae 2 software has received CE marking (class 2b), indicating its conformity with European health, safety, and environmental protection standards. This allows the software to be marketed within the European Economic Area.
2023-09
NUREA Newsroom / Vascular News
Fully automated software could become a u201ccrucial adjunctu201d for EVAR follow-up
An article in Vascular News highlights Nurea's PRAEVAorta software, suggesting that its fully automated capabilities using artificial intelligence could become a crucial tool for follow-up after endovascular aneurysm repair (EVAR).
2022-10
No FAQs available yet for this company.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]

Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.